Solesence, Inc. Common Stock(SLSN)Earnings, Financials & Key Ratios
SLSN•NASDAQ
$1.26
$89M mkt cap·18.0× P/E·Price updated May 6, 2026
AboutSolésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Active Stress Defense™ technology suite to bring environmental protection beauty products to market.Show more
- Revenue$52M+40.4%
- EBITDA$6M+316.1%
- Net Income$4M+196.5%
- EPS (Diluted)0.07+179.0%
- Gross Margin30.92%+47.4%
- EBITDA Margin11.58%+254.0%
- Operating Margin9.8%+203.1%
- Net Margin8.09%+168.7%
- ROE50.27%+143.2%
- ROIC15.31%+223.8%
- Debt/Equity1.02-90.8%
- Interest Coverage7.66+281.0%
SLSN Key Insights
Solesence, Inc. Common Stock (SLSN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Efficient asset utilization: 1.0x turnover
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 13 (bottom 13%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 31.2% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
SLSN Price & Volume
Solesence, Inc. Common Stock (SLSN) stock price & volume — 10-year historical chart
Loading chart...
SLSN Growth Metrics
Solesence, Inc. Common Stock (SLSN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years21.1%
TTM30.04%
Profit CAGR
10 Years-
5 Years-
3 Years22.21%
TTM-59.9%
EPS CAGR
10 Years-
5 Years-
3 Years11.87%
TTM-44.7%
Return on Capital
10 Years1.66%
5 Years1.66%
3 Years-1.84%
Last Year24.72%
SLSN Recent Earnings
Solesence, Inc. Common Stock (SLSN) EPS & revenue vs analyst estimates — last 4 quarters
Q4 2025Latest
Nov 11, 2025EPS
$0.02
Revenue
$15M
Q3 2025
Jul 31, 2025EPS
$0.04
Revenue
$20M
Q2 2025
May 5, 2025EPS
$0.00
Revenue
$15M
Q2 2025
Mar 26, 2025EPS
$0.01
Revenue
$13M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q4 2025Latest | Nov 11, 2025 | $0.02 | $15M |
| Q3 2025 | Jul 31, 2025 | $0.04 | $20M |
| Q2 2025 | May 5, 2025 | $0.00 | $15M |
| Q2 2025 | Mar 26, 2025 | $0.01 | $13M |
Based on last 8 quarters of dataView full earnings history →
SLSN Peer Comparison
Solesence, Inc. Common Stock (SLSN) competitors in Personal Care and Beauty Products — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SKIN | 120.86M | 0.93 | -5.83 | -10.02% | -3.16% | -15.42% | 6.20 | |
 RVLV | 1.44B | 20.19 | 23.48 | 8.48% | 5.05% | 12.84% | 0.06 | |
 ELF | 3.42B | 61.43 | 31.99 | 28.28% | 6.84% | 8.95% | 0.41 | |
 COTY | 2.33B | 2.65 | -6.02 | -3.68% | -9.26% | -14.21% | 1.07 | |
 IPAR | 3.04B | 94.81 | 18.09 | 2.49% | 13.46% | 18.37% | 0.20 | |
 EL | 31.29B | 86.67 | -27.51 | -8.46% | -1.67% | -6.29% | 2.44 | |
 ULTA | 24.48B | 535.10 | 20.87 | 9.71% | 9.31% | 44.07% | 0.78 | |
 HIMS | 6.94B | 26.88 | 52.71 | 59% | 5.47% | 23.73% | 2.07 |
Compare SLSN vs Peers
Solesence, Inc. Common Stock (SLSN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SLSN Income Statement
Solesence, Inc. Common Stock (SLSN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
| Sales/Revenue | 29.48M | 37.32M | 37.3M | 52.35M | 62.15M |
| Revenue Growth % | - | 26.61% | -0.05% | 40.35% | 30.04% |
| Cost of Goods Sold | 20.79M | 28.96M | 29.47M | 36.16M | 46.75M |
| COGS % of Revenue | 70.52% | 77.6% | 79.02% | 69.08% | - |
| Gross Profit | 8.69M▲ 0% | 8.36M▼ 3.8% | 7.83M▼ 6.4% | 16.19M▲ 106.9% | 15.39M▲ 0% |
| Gross Margin % | 29.48% | 22.4% | 20.98% | 30.92% | 24.77% |
| Gross Profit Growth % | - | -3.8% | -6.4% | 106.88% | - |
| Operating Expenses | 6.13M | 10.62M | 11.37M | 11.06M | 14.23M |
| OpEx % of Revenue | 20.8% | 28.45% | 30.49% | 21.12% | - |
| Selling, General & Admin | 3.9M | 7.58M | 7.53M | 7.22M | 10.09M |
| SG&A % of Revenue | 13.22% | 20.32% | 20.2% | 13.79% | - |
| Research & Development | 2.23M | 3.04M | 3.84M | 3.84M | 4.15M |
| R&D % of Revenue | 7.58% | 8.14% | 10.29% | 7.33% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 2.56M▲ 0% | -2.26M▼ 188.2% | -3.55M▼ 57.0% | 5.13M▲ 244.7% | 1.16M▲ 0% |
| Operating Margin % | 8.68% | -6.05% | -9.51% | 9.8% | 1.87% |
| Operating Income Growth % | - | -188.24% | -57.04% | 244.73% | - |
| EBITDA | 3.01M | -1.69M | -2.8M | 6.06M | 2.07M |
| EBITDA Margin % | 10.22% | -4.53% | -7.52% | 11.58% | 3.32% |
| EBITDA Growth % | - | -156.12% | -65.82% | 316.12% | -52.8% |
| D&A (Non-Cash Add-back) | 454K | 567K | 742K | 928K | 904K |
| EBIT | 3.51M | -2.26M | -3.55M | 5.13M | 2.4M |
| Net Interest Income | -1.15M | -382K | -838K | -670K | -710K |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.15M | 382K | 838K | 670K | 710K |
| Other Income/Expense | -202K | -382K | -838K | -670K | 524K |
| Pretax Income | 2.36M▲ 0% | -2.64M▼ 212.0% | -4.38M▼ 66.1% | 4.46M▲ 201.8% | 1.69M▲ 0% |
| Pretax Margin % | 8% | -7.07% | -11.75% | 8.52% | 2.71% |
| Income Tax | 37K | -17K | 6K | 227K | 617K |
| Effective Tax Rate % | 1.57% | 0.64% | -0.14% | 5.09% | 36.6% |
| Net Income | 2.32M▲ 0% | -2.62M▼ 213.1% | -4.39M▼ 67.4% | 4.24M▲ 196.5% | 1.07M▲ 0% |
| Net Margin % | 7.87% | -7.03% | -11.77% | 8.09% | 1.72% |
| Net Income Growth % | - | -213.06% | -67.37% | 196.47% | -59.9% |
| Net Income (Continuing) | 2.32M | -2.62M | -4.39M | 4.24M | 1.07M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.05▲ 0% | -0.05▼ 206.8% | -0.09▼ 65.9% | 0.07▲ 179.0% | 0.02▲ 0% |
| EPS Growth % | - | -206.8% | -65.92% | 179.01% | -44.7% |
| EPS (Basic) | 0.05 | -0.05 | -0.09 | 0.07 | - |
| Diluted Shares Outstanding | 47.04M | 49.12M | 49.56M | 65.03M | 70.5M |
| Basic Shares Outstanding | 45.02M | 49.12M | 49.56M | 62.35M | 70.5M |
| Dividend Payout Ratio | - | - | - | - | - |
SLSN Balance Sheet
Solesence, Inc. Common Stock (SLSN) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
| Total Current Assets | 11.6M | 16.63M | 16.3M | 29.35M | 32.79M |
| Cash & Short-Term Investments | 657K | 2.19M | 1.72M | 1.41M | 429K |
| Cash Only | 657K | 2.19M | 1.72M | 1.41M | 429K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.94M | 4.73M | 3.47M | 4.87M | 9.71M |
| Days Sales Outstanding | 48.75 | 46.3 | 33.93 | 33.95 | 50.97 |
| Inventory | 6.09M | 8.84M | 10.03M | 20.27M | 18.87M |
| Days Inventory Outstanding | 107.03 | 111.41 | 124.23 | 204.58 | 157.86 |
| Other Current Assets | 0 | 866K | 1.08M | 2.8M | 0 |
| Total Non-Current Assets | 16.8M | 16.93M | 16.58M | 20.65M | 21.2M |
| Property, Plant & Equipment | 16.79M | 16.93M | 16.57M | 20.65M | 21.2M |
| Fixed Asset Turnover | 1.76x | 2.20x | 2.25x | 2.53x | 2.95x |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 8K | 6K | 4K | 3K | 4K |
| Total Assets | 28.39M▲ 0% | 33.56M▲ 18.2% | 32.88M▼ 2.0% | 50M▲ 52.1% | 53.99M▲ 0% |
| Asset Turnover | 1.04x | 1.11x | 1.13x | 1.05x | 1.13x |
| Asset Growth % | - | 18.19% | -2.02% | 52.07% | 159.29% |
| Total Current Liabilities | 7.34M | 13.84M | 15.59M | 25.77M | 17.86M |
| Accounts Payable | 3.89M | 6.77M | 6.39M | 10.69M | 4.83M |
| Days Payables Outstanding | 68.24 | 85.28 | 79.11 | 107.91 | 61.63 |
| Short-Term Debt | 1.35M | 4.28M | 4.81M | 5M | 5.32M |
| Deferred Revenue (Current) | 905K | 2.23M | 2.35M | 5.57M | 12.36M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 1.2M |
| Current Ratio | 1.58x | 1.20x | 1.05x | 1.14x | 1.14x |
| Quick Ratio | 0.75x | 0.56x | 0.40x | 0.35x | 0.35x |
| Cash Conversion Cycle | 87.55 | 72.43 | 79.05 | 130.62 | 147.2 |
| Total Non-Current Liabilities | 13.59M | 14.07M | 15.39M | 9.28M | 18.9M |
| Long-Term Debt | 1M | 4M | 6M | 0 | 10.5M |
| Capital Lease Obligations | 11.71M | 9.82M | 9.15M | 9.04M | 34.4M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 222K | 230K | 238K | 246K | 996K |
| Total Liabilities | 20.93M | 27.91M | 30.98M | 35.06M | 36.76M |
| Total Debt | 14.75M | 18.11M | 21.26M | 15.3M | 25.18M |
| Net Debt | 14.09M | 15.92M | 19.54M | 13.89M | 24.75M |
| Debt / Equity | 1.98x | 3.20x | 11.18x | 1.02x | 1.02x |
| Debt / EBITDA | 4.90x | - | - | 2.52x | 12.19x |
| Net Debt / EBITDA | 4.68x | - | - | 2.29x | 2.29x |
| Interest Coverage | 2.22x | -5.91x | -4.23x | 7.66x | 3.37x |
| Total Equity | 7.46M▲ 0% | 5.65M▼ 24.3% | 1.9M▼ 66.3% | 14.95M▲ 685.8% | 17.23M▲ 0% |
| Equity Growth % | - | -24.33% | -66.33% | 685.8% | 958.02% |
| Book Value per Share | 0.16 | 0.12 | 0.04 | 0.23 | 0.24 |
| Total Shareholders' Equity | 7.46M | 5.65M | 1.9M | 14.95M | 17.23M |
| Common Stock | 489K | 493K | 496K | 700K | 705K |
| Retained Earnings | -97.45M | -100.07M | -104.66M | -100.43M | -98.8M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
SLSN Cash Flow Statement
Solesence, Inc. Common Stock (SLSN) cash flow — operating, investing & free cash flow history
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
| Cash from Operations | 2.32M | -1.65M | -2.01M | 1.97M | 1.97M |
| Operating CF Margin % | 7.87% | -4.42% | -5.38% | 3.77% | - |
| Operating CF Growth % | - | -171.09% | -21.58% | 198.26% | -80.22% |
| Net Income | 2.32M | -2.62M | -4.39M | 4.24M | 1.07M |
| Depreciation & Amortization | 454K | 567K | 742K | 928K | 904K |
| Stock-Based Compensation | 160K | 625K | 773K | 725K | 617K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -49K | 2.57M | 0 | 0 | 0 |
| Working Capital Changes | -564K | -2.79M | 869K | -3.92M | -10.79M |
| Change in Receivables | -1M | -797K | 1.06M | -1.4M | -977K |
| Change in Inventory | -1.75M | -2.74M | -1.19M | -10.24M | -3.83M |
| Change in Payables | 1.03M | 0 | -503K | 2.4M | -2.06M |
| Cash from Investing | -1.87M | -2.82M | -1.05M | -4.56M | -4.29M |
| Capital Expenditures | -1.87M | -2.82M | -1.05M | -4.56M | -4.42M |
| CapEx % of Revenue | 6.36% | 7.56% | 2.82% | 8.71% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 133K |
| Cash from Financing | -747K | 6M | 2.59M | 2.27M | 9.99M |
| Debt Issued (Net) | -981K | -111K | 2.52M | -5.81M | 9.61M |
| Equity Issued (Net) | 0 | 0 | 0 | 1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 234K | 6.11M | 73K | 2.08M | 374K |
| Net Change in Cash | -300K▲ 0% | 1.53M▲ 609.7% | -464K▼ 130.3% | -313K▲ 32.5% | -2.5M▲ 0% |
| Free Cash Flow | 447K▲ 0% | -4.47M▼ 1100.7% | -3.06M▲ 31.7% | -2.59M▲ 15.4% | -11.21M▲ 0% |
| FCF Margin % | 1.52% | -11.99% | -8.2% | -4.94% | -18.03% |
| FCF Growth % | - | -1100.67% | 31.66% | 15.37% | -122.73% |
| FCF per Share | 0.01 | -0.09 | -0.06 | -0.04 | -0.04 |
| FCF Conversion (FCF/Net Income) | 1.00x | 0.63x | 0.46x | 0.47x | -10.48x |
| Interest Paid | 218K | 333K | 752K | 637K | 811K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |
SLSN Key Ratios
Solesence, Inc. Common Stock (SLSN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|
| Return on Equity (ROE) | -40% | -116.28% | 50.27% | 6.21% |
| Return on Invested Capital (ROIC) | -7.85% | -12.37% | 15.31% | 15.31% |
| Gross Margin | 22.4% | 20.98% | 30.92% | 24.77% |
| Net Margin | -7.03% | -11.77% | 8.09% | 1.72% |
| Debt / Equity | 3.20x | 11.18x | 1.02x | 1.02x |
| Interest Coverage | -5.91x | -4.23x | 7.66x | 3.37x |
| FCF Conversion | 0.63x | 0.46x | 0.47x | -10.48x |
| Revenue Growth | 26.61% | -0.05% | 40.35% | 30.04% |
SLSN Frequently Asked Questions
Solesence, Inc. Common Stock (SLSN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Solesence, Inc. Common Stock (SLSN) reported $62.1M in revenue for fiscal year 2024. This represents a 111% increase from $29.5M in 2021.
Solesence, Inc. Common Stock (SLSN) grew revenue by 40.4% over the past year. This is strong growth.
Yes, Solesence, Inc. Common Stock (SLSN) is profitable, generating $1.1M in net income for fiscal year 2024 (8.1% net margin).
Dividend & Returns
Solesence, Inc. Common Stock (SLSN) has a return on equity (ROE) of 50.3%. This is excellent, indicating efficient use of shareholder capital.
Solesence, Inc. Common Stock (SLSN) had negative free cash flow of $11.2M in fiscal year 2024, likely due to heavy capital investments.
Explore More SLSN
Solesence, Inc. Common Stock (SLSN) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates